Early research (Phase 1)Active Not RecruitingNCT06155500
What this trial is testing
Long-term Follow-up (LTFU) of Patients Treated With Genome-edited Autologous Hematopoietic Stem and Progenitor Cells (HSPC)
Who this might be right for
Sickle Cell Disease
Novartis Pharmaceuticals 4